Based on the current evidence, we hypothesize that soluble CD27 functions as a predictive biomarker in ICI across multiple cancer types, while EV-bound CD27, despite playing an opposite immunological role, also functions as a predictive biomarker in this setting. This evidence concerns the gene CD27 and cancer.